Research
Cellular
The pathogenesis of obesity-related glomerulopathy is complex, involving multiple factors.
Recognizing the complexity of ORG can guide more targeted therapeutic approaches.
StrongSupportsmedium confidence
The pathogenesis of ORG is complex, involving altered renal hemodynamics, activation of the renin–angiotensin–aldosterone system, insulin resistance, and abnormal lipid metabolism and adipokines.
Why this rating
The claim is based on a comprehensive overview of the pathogenesis presented in the abstract.
Source
Obesity-Related Glomerulopathy: Epidemiology, Pathogenesis, and Current Treatments
Xinyu Yang et al. · Integrative Medicine in Nephrology and Andrology · 2024
DOI 10.1097/imna-d-24-00011
reviewCited 8×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Approximately 10% of obesity-related glomerulopathy (ORG) patients progress to end stage renal disease 6.2 years after diagnosis.Strong
- New glucose-lowering drugs, such as sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists, have been confirmed to reduce weight and preserve kidney function.Strong
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →